The Effect of Mitochondrial Supplements on Mitochondrial Activity in Children with Autism Spectrum Disorder
1
Arkansas Children’s Research Institute, Little Rock, AR 72202, USA
2
Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AR 72202, USA
3
Child and Adolescent Department, Mental Health Centre, West China Hospital of Sichuan University, Chengdu 610041, China
4
Department of Pediatrics, Drexel University College of Medicine, Neurology Section, St. Christopher’s Hospital for Children, Philadelphia, PA 19134, USA
*
Author to whom correspondence should be addressed.
Academic Editor: Ian P. Hargreaves
J. Clin. Med. 2017, 6(2), 18; https://doi.org/10.3390/jcm6020018
Received: 31 December 2016 / Revised: 16 January 2017 / Accepted: 6 February 2017 / Published: 13 February 2017
(This article belongs to the Special Issue Current Strategies for the Biochemical Diagnosis and Monitoring of Mitochondrial Disease)
Abstract
Treatment for mitochondrial dysfunction is typically guided by expert opinion with a paucity of empirical evidence of the effect of treatment on mitochondrial activity. We examined citrate synthase and Complex I and IV activities using a validated buccal swab method in 127 children with autism spectrum disorder with and without mitochondrial disease, a portion of which were on common mitochondrial supplements. Mixed-model linear regression determined whether specific supplements altered the absolute mitochondrial activity as well as the relationship between the activities of mitochondrial components. Complex I activity was increased by fatty acid and folate supplementation, but folate only effected those with mitochondrial disease. Citrate synthase activity was increased by antioxidant supplementation but only for the mitochondrial disease subgroup. The relationship between Complex I and IV was modulated by folate while the relationship between Complex I and Citrate Synthase was modulated by both folate and B12. This study provides empirical support for common mitochondrial treatments and demonstrates that the relationship between activities of mitochondrial components might be a marker to follow in addition to absolute activities. Measurements of mitochondrial activity that can be practically repeated over time may be very useful to monitor the biochemical effects of treatments. View Full-TextKeywords:
antioxidants; autism spectrum disorder; B12; Complex I; Complex IV; electron transport chain; fatty acids; folate; mitochondrial disease; mitochondrial dysfunction
▼
Figures
Figure 1
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
Share & Cite This Article
MDPI and ACS Style
Delhey, L.M.; Nur Kilinc, E.; Yin, L.; Slattery, J.C.; Tippett, M.L.; Rose, S.; Bennuri, S.C.; Kahler, S.G.; Damle, S.; Legido, A.; Goldenthal, M.J.; Frye, R.E. The Effect of Mitochondrial Supplements on Mitochondrial Activity in Children with Autism Spectrum Disorder. J. Clin. Med. 2017, 6, 18.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.
Related Articles
Article Metrics
Comments
[Return to top]
J. Clin. Med.
EISSN 2077-0383
Published by MDPI AG, Basel, Switzerland
RSS
E-Mail Table of Contents Alert